Results of the phase II TRUST trial of induction treatment with FOLFOXIRI + bevacizumab (BV) followed by chemo-radiotherapy (CRT) plus BV and surgery in locally advanced rectal carcinoma (LARC).

Authors

null

Gianluca Masi

Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy

Gianluca Masi , Sara Lonardi , Aldo Sainato , Piero Buccianti , Giacomo Allegrini , Angelo Martignetti , Caterina Vivaldi , Francesca Bergamo , Sabrina Montrone , Matteo Franceschi , Lorenzo Marcucci , Gianna Musettini , Francesca Battaglin , Gabriele Coraggio , Riccardo Balestri , Chiara Cremolini , Isabella Paladina , Lisa Salvatore , Vittorina Zagonel , Alfredo Falcone

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

2011-003340-45

Citation

J Clin Oncol 34, 2016 (suppl; abstr 3615)

DOI

10.1200/JCO.2016.34.15_suppl.3615

Abstract #

3615

Poster Bd #

312

Abstract Disclosures